Cargando…
B cell therapy and the use of RNA-based COVID-19 vaccines
Autores principales: | Vishnevetsky, Anastasia, Hawkes, Chris, Lechner-Scott, Jeannette, Giovannoni, Gavin, Levy, Michael, Pohl, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938733/ https://www.ncbi.nlm.nih.gov/pubmed/33883063 http://dx.doi.org/10.1016/j.msard.2021.102887 |
Ejemplares similares
-
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis
por: Salama, Sara, et al.
Publicado: (2020) -
Pulmonary Circulation : A new venue for communicating your findings, ideas and perspectives
por: Yuan, Jason X.-J., et al.
Publicado: (2011) -
Society of Biological Psychiatry’s 75th Anniversary Meeting: A Guide to the Meeting That Wasn't
por: Berman, Karen F., et al.
Publicado: (2020) -
COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021) -
The COVID-19 pandemic and the use of MS disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2020)